Connecticut Attorney General William Tong announced four separate settlements with hearing aid companies: Lively Hearing Corporation, Widex USA, Inc., Hark Wellness, Inc., and Wonder Ear, Inc., who marketed their products as “FDA-approved” despite no such approval.
Hearing aids currently do not receive approval from the United States Food and Drug Administration (FDA) in the same manner as new drugs and some medical devices; however, hearing aid manufacturers register their products with the FDA.
Although Congress enacted legislation in 2017 permitting the FDA to create a category of over-the-counter (OTC) hearing aids, the FDA has not yet issued a final rule and no hearing aid suppliers should be marketing their products as OTC or “FDA-approved.”
Recent Posts
Appropriations Update
As Congress returns from the August recess, its primary goal is to pass the appropriations bills that fund the federal government by September 30, 2025….
Clinical Decision Support for Vestibular Diagnosis: Large-Scale Machine Learning with Lived Experience Coaching
Pastor et al. (2025) developed a machine learning system (MLS) to help make a vestibular diagnosis based on patient symptoms. They utilized diagnostic data from…
Academy Submits Comments on Proposed Revisions to MPFS CY 2026
In response to the Centers for Medicare and Medicaid Services (CMS) Notice of Proposed Rulemaking (NPRM) regarding revisions to Medicare payment policies under the Medicare…